Navigation Links
Collaboration between Sanofi and Joslin Diabetes Center to focus on new drugs for diabetes
Date:6/19/2012

e team, added: "This opportunity brings together experts from the pharmaceutical industry with our team of scientists and clinicians, who are devoted to research and clinical care for diabetes and related metabolic disorders. The result should be a very exciting collaboration with great potential for innovative research that will participate to advance diabetes treatment and patient care."

Financial details of the collaboration were not disclosed.  

About Joslin Diabetes CenterJoslin Diabetes Center is the world's leading diabetes research and clinical care organization. At Joslin, the world's best researchers and clinicians prevent, treat and strive to cure diabetes and its complications. Among the Harvard Medical School Affiliated institutions, Joslin is one of the most research-intensive academic medical centers and is unique in its sole focus on diabetes. Their discoveries improve the lives of people with diabetes worldwide and offer the greatest hope for a cure. Founded in 1898 by a single physician, Elliott P. Joslin, M.D., Joslin today has more than 600 employees in three major divisions: Joslin Research, a highly collaborative team of more than 300 people with 41 faculty level investigators undertaking the largest research program aimed at preventing and curing type 1 and type 2 diabetes and their long-term complications and more than 120 MD and PhD fellows in training; Joslin Clinic, the world's first and most respected diabetes care facility, which cares for 23,000 adult and pediatric patients a year, focusing on aggressive and comprehensive patient care from highly specialized and multi-skilled experts; and Joslin Strategic Initiatives, which develops and markets innovative programs, products and services that expand the availability of Joslin knowledge and expertise to patients and clinicians around the globe to improve the quality of diabetes care.

About Sanofi Diabetes Sanofi strives to help people manage the com
'/>"/>

SOURCE Sanofi
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. RayBiotech, Inc. and the University of Oslo Enter into Antibody Array Services Collaboration
2. Big Pharma and Universities Increasingly Work to Advance Life Science Knowledge by Forming Strategic Partnerships, Public-Private Partnerships, and Open Innovation Programs: Pharmaceutical Research Collaborations Summit
3. Trovagene and Strand Life Sciences Plan Collaboration to Validate and Offer Urine-Based HPV Screening Test in India and South Asia
4. Daiichi Sankyo And Coherus BioSciences Establish Strategic Collaboration To Develop And Commercialize Biosimilar Candidates
5. Butamax™ and Fagen Announce Collaboration to Retrofit Ethanol Plants for Biobutanol Production
6. Medivir Announces TMC435 in an Expanded Clinical Collaboration
7. Intellect Neurosciences Enters Collaboration Agreement with Leading Alzheimers Research Group at University of California Irvine to Test First in Class Dual Target Vaccine
8. Aviir Diagnostics Laboratory in Collaboration with Cause;ology Sponsors "Storyland," a Red Carpet Charity Extravaganza in Hollywood
9. Apexigen and Shanghai Duyiwei Biotechnology Co. Ltd Sign a License and Collaboration Agreement to Develop and Commercialize APX004
10. Volition Signs Collaboration Agreement With Abcodia
11. BioCrossroads Commemorates Decade of Collaboration, Success for Indiana Life Sciences Sector
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... SAN DIEGO , Nov. 20, 2014 /PRNewswire/ ... and CEO Marc Hedrick , M.D. will present live ... Thursday, December 4, 2014 TIME:    11:15 am PT ... or paste this URL into your browser,s address bar: ... to save time and receive event updates. ...
(Date:11/18/2014)... LA (PRWEB) November 17, 2014 ... build-to-order, open architecture blade-based and rackmount computing infrastructure, ... Tesla® K80 dual-GPU accelerator throughout its GPU-enabled blade ... pair of the company’s latest proprietary 80-lane Gen3 ... eight discrete NVIDIA Tesla K80 dual-GPU accelerator cards ...
(Date:11/18/2014)... American Process Inc. (Atlanta, GA) and ... with researchers at Georgia Institute of Technology, Clark ... USDA’s Forest Products Laboratory to develop ultra-strong, lightweight ... a rapidly emerging high performance nanomaterial extracted from ... replace heavy steel structures within cars, such as ...
(Date:11/18/2014)... Nov. 18, 2014 PDL BioPharma, Inc. (PDL) ... connection with the acquisition of Durata Therapeutics, Inc. by ... with the termination of PDL,s credit agreement with Durata, ... of $40 million, accrued interest, and prepayment and change ... a structured financing transaction with Durata in which PDL ...
Breaking Biology Technology:Cytori Therapeutics to Provide Corporate Update and Investor Presentation on December 4 through a Live, Interactive Webcast 2Cytori Therapeutics to Provide Corporate Update and Investor Presentation on December 4 through a Live, Interactive Webcast 3Cytori Therapeutics to Provide Corporate Update and Investor Presentation on December 4 through a Live, Interactive Webcast 4Cirrascale® Expands Multi-GPU Peering Solutions with Support for New NVIDIA Tesla K80 Dual-GPU Accelerators 2Cirrascale® Expands Multi-GPU Peering Solutions with Support for New NVIDIA Tesla K80 Dual-GPU Accelerators 3American Process Inc. Announces Partnership to Develop Ultra-Strong, Lightweight Automotive Components Using Nanotechnology from Nature 2American Process Inc. Announces Partnership to Develop Ultra-Strong, Lightweight Automotive Components Using Nanotechnology from Nature 3PDL BioPharma Announces Successful Conclusion of Debt Financing Agreement with Durata Therapeutics 2
... Biomedtex Inc. (Pink,Sheets: BMDX.PK) ("The Company") a ... The Company,s mission is to identify, evaluate ... and healthcare solutions, and then,seek to capture and ... For more information visit us at http://WWW.BIOMEDTEX.COM ...
... Inverness Medical,Innovations (Amex: IMA ) today announced that ... Ltd, an Australian company traded on,the Australian Securities Exchange, ... of the issued shares in Panbio for AUD 0.65 ... share capital of,Panbio at approximately AUD 41 million, or ...
... are Honored ... Meeting, Laguna Niguel, LAGUNA NIGUEL, Calif., Oct. 8 ... CEO-only conference hosted by,Burrill & Company and Kleiner Perkins Caufield ... at an Awards Dinner held here Sunday,evening. For twenty ...
Cached Biology Technology:Inverness Medical Innovations Agrees to Acquire Panbio Ltd. 2Biotech Hall of Fame Inductees Announced 2Biotech Hall of Fame Inductees Announced 3Biotech Hall of Fame Inductees Announced 4Biotech Hall of Fame Inductees Announced 5Biotech Hall of Fame Inductees Announced 6
(Date:11/4/2014)... death at the right time might actually help boost ... could help in understanding animal populations, pest control and ... in the journal Trends in Ecology and Evolution ... that the kind of positive population effect an overall ... depends on the size and developmental stage of the ...
(Date:11/4/2014)... GABLES, Fla. (November 4, 2014) — Think about the ... ask: How do neighboring cells know that they are ... and how do these tissues find the correct place ... are answering these crucial questions. , In a new ... use to communicate with their surrounding neighbors, at the ...
(Date:11/4/2014)... , November 4, 2014   ... vertical market growth   Fuel3D , a ... closed a funding round totaling $6.4 million (£4 million). This ... funding secured earlier this year and paves the way for ... 2015. The funding round was led by Chimera ...
Breaking Biology News(10 mins):When less is more: Death in moderation boosts population density in nature 2The inside story: How the brain and skull stay together 2Fuel3D Secures $6.4 Million in Expansion Funding 2Fuel3D Secures $6.4 Million in Expansion Funding 3
... that honey bees "self-medicate" when their colony is infected ... antifungal plant resins to ward off the pathogen. ... effort of its worker bees to collect these resins," ... NC State,s Department of Entomology and lead author of ...
... A proposed study could help determine if there is a ... facilities and having a higher risk of cancer, but challenges ... Research Council, the operating arm of the National Academy of ... that a pilot study be completed first to evaluate the ...
... Peninsula, such as the Iberian lynx, are under an increasingly ... and that can even survive in extremely arid environments. A ... ticks to adapt according to climate. The life cycle ... movement patterns of people and goods. These parasites and the ...
Cached Biology News:Bees 'self-medicate' when infected with some pathogens 2Report presents designs for study of cancer risks near US nuclear facilities 2Report presents designs for study of cancer risks near US nuclear facilities 3Ticks can adapt to the Spain's climatic diversity 2
Hygromycin resistance gene (hph), provided in a pORF plasmid. pORF is an expression plasmid selectable with Ampicillin....
... designed to allow neomycin/kanamycin selection in ... loxP-PGK-gb2-neo-loxP template encodes the neomycin/kanamycin resistance ... (gb2) for expression of kanamycin resistance ... (PGK) for expression of neomycin resistance ...
... isolations. The kit provides a simple and ... from normal c lture using annexin V ... Ca2+-dependent phospholipid binding protein with high affinity ... Kit provides a simple and efficient means ...
... is tailored to highly enrich ... of rat spleen cells. Cells ... (or compatible 0.5 Tesla) immunomagnetic ... CD4+ T cell content of ...
Biology Products: